vanadates has been researched along with Choriocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, SP; Thakar, J; Van Twisk, D | 1 |
| Acunzo, G; Beguinot, F; Bifulco, G; Caruso, M; Di Carlo, C; Nappi, C; Pellicano, M; Votino, C | 1 |
2 other study(ies) available for vanadates and Choriocarcinoma
| Article | Year |
|---|---|
Optimized logic rules reveal interferon-γ-induced modes regulated by histone deacetylases and protein tyrosine phosphatases.
Topics: Animals; Cell Line, Tumor; Choriocarcinoma; Computer Simulation; Epigenetic Repression; Female; Gene Expression Profiling; Gene Expression Regulation; Histone Deacetylases; Humans; Interferon-gamma; Mice; Placentation; Pregnancy; Protein Tyrosine Phosphatases; Response Elements; Valproic Acid; Vanadates | 2017 |
Vanadate regulates the insulin mitogenic effect by modulating SHP-2 association with insulin receptor substrate 1 in JAr human choriocarcinoma cells.
Topics: Cell Division; Choriocarcinoma; Enzyme Activation; Female; Glucose; Humans; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Placenta; Pregnancy; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Tumor Cells, Cultured; Uterine Neoplasms; Vanadates | 2003 |